Every Day Your Dossier Stalls, Your Competitors Capture Your Market Share

Stop letting technical deficiencies kill your commercial window.

We provide elite pre-submission audits and deficiency rescue for ACTD, CTD, eCTD submissions.

Core Regulatory Expertise

We handle the actual science and compliance of your filing. Instead of just forwarding supplier documents, we audit and correct the core data across your entire ACTD or eCTD submission.

Our team comprised of ex-regulators, manages the regional administrative requirements, audits the CMC data for quality compliance, and directly validates complex clinical and Bioequivalence (BE) studies to ensure your product meets strict Health Authority standards.

Scientist uses pipette to extract liquid in a lab.
Scientist uses pipette to extract liquid in a lab.
assorted files
assorted files

The Regustat Advantage

Most agencies act as simple document couriers. We operate as technical consultants. We bridge the gap between raw manufacturer data and strict regulator demands. We audit your supplier's files, pinpoint critical deficiencies, and provide a definitive, actionable roadmap to bring your submission up to standard.

Technical Solutions

Strategic dossier architecture and rapid deficiency remediation for high-stakes approvals.

Submission De-risking
two people shaking hands in front of a laptop
two people shaking hands in front of a laptop

Exhaustive pre-submission diagnostics to identify critical CMC and clinical gaps. We ensure absolute structural integrity of your dossier to improve immediate pre-assessment acceptance by Health Authorities.

brown wooden hand tool on white printer paper
brown wooden hand tool on white printer paper
A semaglutide injection pen is shown.
A semaglutide injection pen is shown.
Deficiency Response & Rescue

Immediate technical intervention for critical deficiencies. We take unoptimized, raw supplier data and thoroughly re-architect it into a rigorous, regulator-approved format—eliminating friction and securing your commercial clearance.

Specialized regulatory mapping for biologicals, orphan drugs, and novel therapeutics. We execute forensic diagnostics on dense Bioequivalence (BE) and clinical data to forge a definitive market pathway for your most difficult products.

Complex Asset Architecture